We're committed to providing you with the very best cancer care, and your safety continues to be a top priority. With this in mind, we’ve put in place many new procedures, including a limited visitor policy. This is just one more way of ensuring your safety and that of our staff. Read more
Scott Avecilla, MD, PhD
Medical and Scientific Director, Cell Therapy Laboratory Services
Cell Therapy; Coagulation and Hemostasis; Transfusion Medicine; Apheresis
PhD, Weill Cornell Graduate School of Medical Sciences; MD, Weill Cornell Medical College
Clinical Pathology - University of Washington
Transfusion Medicine and Blood Banking - New York Blood Center
Clinical Pathology; Blood Banking/Transfusion Medicine
I am a clinical pathologist who specializes in the field of cellular therapy, which uses human cells to treat diseases such as leukemia, lymphoma, myeloma, and other cancers where blood stem cell transplantation is the treatment of choice. As the medical and scientific director for the Cell Therapy Laboratory Service, I work with laboratory staff management to ensure that all processes and procedures used in the production of cellular therapy products are of the highest quality. I also work closely with my colleagues in the Bone Marrow Transplant Service to ensure that the needs of the patients are met in the most state-of-the-art and cost-effective manner.
I have a strong interest in pursuing collaborative research and development objectives with my colleagues within the Department of Laboratory Medicine, the Bone Marrow Transplant Service, and other members of the MSK community. We strive to optimize hematopoietic progenitor cell (HPC) harvest protocols, develop better laboratory assays to standardize current HPC potency assays, and to work with the Flow Cytometry Laboratory to investigate enhanced flow cytometry processing and analysis protocols for HPC product characterization. We are also developing new processes to prevent graft-versus-host-disease by ways of novel ex vivo cell selections procedures.
Awards and Honors
Spirit of Transplant Award, FACT Cell Processing and Apheresis Teams (2017)
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Scott Avecilla discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].